The report is very encouraging that the board are doing a great job and this company has huge potential, obviously, the tree shakes have scared some holders off, whilst others are grinning getting them so cheap.
Beneficiation Plant design and capital and processing cost estimates for lump, 2mm concentrate and 106 micron concentrate options. ❖ Capital and operating costs for Vat Leach operation, comparing lump and concentrate scenarios. ❖ Options analysis into the capital and operating costs for an on-site Sulphuric Acid Plant compared to importing acid and contract diesel power generation, including the supply, port access and transport of sulphur and sulphuric acid. ❖ Geotechnical studies on drill core to help finalise pit design. ❖ Environmental, heritage and marketing studies.
The Board is most encouraged by the new vat and column leach test results, particularly the flooded column result as it most closely resembles a vat leach operation. Successful conclusion of the tests will allow us to finalise the vat leach plant design and costings as soon as possible. A trade-off analysis into the optimum particle size will be undertaken. This will examine the merits of both a vat leach operation using lump magnetite gabbro compared to an agitated tank system using concentrate. During 2019, KRR aims to present shareholders with the most prudent commercial strategy to develop the Speewah vanadium deposits and advance towards the production of a basket of Specialty products, including Vanadium, Titanium, Iron and other high value products at the lowest possible unit cost.
Hang in there for the ride people otherwise, you will be kicking yourself in the future
GLTAH and DYOR
- Forums
- ASX - By Stock
- KRR
- Ann: Positive VAT Leach Test Results
Ann: Positive VAT Leach Test Results, page-3
-
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KRR (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.2¢ |
Change
-0.001(7.69%) |
Mkt cap ! $13.75M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.2¢ | $8.83K | 735.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 236112 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 1876614 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 6200311 | 0.009 |
8 | 28480304 | 0.008 |
5 | 5799516 | 0.007 |
6 | 5100808 | 0.006 |
12 | 8038888 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 1100000 | 2 |
0.011 | 2390000 | 4 |
0.012 | 1242985 | 7 |
0.013 | 1846567 | 8 |
0.014 | 972413 | 7 |
Last trade - 11.28am 25/11/2024 (20 minute delay) ? |
Featured News
KRR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online